---

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.

**FORM 10-KSB**

[ X ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE  ACT OF 1934

For the fiscal year ended **September 30, 2003**

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

Commission File No. **2-94704-NY**

**MedXLink, Corp.**(Exact name of Registrant as specified in its charter)

**Nevada**                                                                           
**11-2647209**                (State or other jurisdiction of                                                          (IRS Employer
                  incorporation or organization)                                                        Identification No.)

**378 North Main, #124; Layton, UT 84041**(Address and zip code of principal executive offices)

Registrant's telephone number, including area code:******(801) 497-9075**

Securities registered pursuant to Section 12(b) of the Act: **NONE**Securities registered pursuant to Section 12(g) of the Act: **NONE**

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required
to file such reports, and (2) has been subject to such filing requirements for the past 90 days. **[ X ] Yes [ ] No**

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and
will not be contained, to the best of Registrant's knowledge, in definitive proxy or information statements incorporated by
reference in Part III of this Form 10-KSB or any amendment to this Form 10-KSB. **[ x ]**

Revenue for the year ended September 30, 2003: $ 0.

As of January 12, 2004 it is unclear as to the aggregate market value of the voting stock held by non-affiliates of the
Registrant. This is due to the low or almost non-existing trading of the Registrant's Securities.

As of January 12, 2004 the number of shares outstanding of the Registrant's Common Stock was 2,487,794.



---

**PART I**

---

MedXLink, Corp., ("the Company") was organized in May 1983 in the State of New York
under the name "National Thoroughbred Corporation." Subsequently, the name was changed to
"NTC Holdings, Inc.".  Although originally formed to engage in purchasing, breeding and selling
Thoroughbred horses, the company's management anticipates merging with an as yet unidentified
on-going business in the future.

The board of directors feel that the Company does not meet the criteria of a development
stage company (as defined in SFAS 7 "*Accounting and Reporting by Development Stage
Enterprises*") primarily because it is not currently producing or marketing a product or service.
However, the Company is currently seeking a business opportunity to merge with or acquire, but to
date has not located any such business opportunities.

In seeking a business opportunity to merge with or acquire, management is reviewing various
business plans. Management has not limited their review of plans or exploration of acquisitions to
any particular industry or service sector.   Management has not yet identified a business to complete
such a transaction with and the Company has not entered into any binding agreements for an
acquisition or merger. There is no assurance that the Company will be successful in finding any
business opportunity to merge with or acquire.

On July 5, 2002 Articles of Merger were filed with the state of Nevada, merging NTC
Holdings, Inc. a New York corporation into Medeport, Inc. a Nevada Corporation for the purpose
of changing  domicile.  On July 12, 2002 the name was changed from Medeport, Inc. to MedXLink
Corp.  The shareholders agreed to eliminate the Class A Preferred stock of 1 share ($.001 par value)
and the Class B Preferred stock of 1,000,000 shares ($.001 par value).  Both classes of preferred
stock had no shares issued and outstanding.

Effective July 21, 2002 the Company entered into an agreement to acquire all of the equity
of eHDL, Inc. ("eHDL").  In anticipation of the transaction the Company sold approximately
$195,000 in debentures and loaned the proceeds to eHDL.  The transaction was not scheduled to
close, however, until and unless eHDL obtained 1) $1 million in funding, 2) converted its existing
debt to equity and 3) obtained audited financial statements.  Due to eHDL's failure in meeting their
requirements to complete the acquisition, the transaction has been abandoned.

**ITEM 2. DESCRIPTION OF PROPERTY**

The Company currently operates from the office of the Company's legal counsel and pays no
rent or expenses.

**ITEM 3. LEGAL PROCEEDINGS**

Effective July 21, 2002 the Company entered into an agreement to acquire all of the equity
of eHDL, Inc. ("eHDL").  In anticipation of the transaction the Company sold approximately
$195,000 in debentures and loaned the proceeds to eHDL.  The transaction was not scheduled to
close, however, until and unless eHDL obtained 1) $1 million in funding, 2) converted its existing
debt to equity and 3) obtained audited financial statements.  Due to eHDL's failure in meeting their
requirements to complete the acquisition, the transaction has been abandoned and in June 2003 a
Complaint was filed in Florida for breach of contract in the amount of $195,000.  Effective July 30,
2003, all of the  investors agreed that all funds recorded as payables on the records of  the Company
will be recorded as investments into eHDL. The related funds payable the investors,  the
corresponding receivable from eHDL , all interest receivable and payable will be reversed on the
books of the Company.  Subsequent to year end, the lawsuit has  been satisfied and the Company
intends to dismiss it.

None.

---

**PART II**

---

The Company is not currently trading in any public markets.  The symbol for the Company
is MXLK and trades on the OTC Bulletin Board.  As of January 7, 2004, the Company had
approximately 170 shareholders of record.

The Company has not declared any cash dividends on its Common Stock since inception and
its Board of Directors has no present intention of declaring any dividends. For the foreseeable future,
the Company intends to retain all earnings, if any, for use in the development and expansion of its
business.

**ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS**

**Financial Condition**

Total stockholders' deficit for the year ending September 30, 2003 was $(122,506), as
compared to $(110,854) at September 30, 2002. The Company has no operating capital for future
operations.

**Liquidity and Capital Resources**

The Company has minimal assets and is currently in the process of looking for business
opportunities to merge with or acquire. During the next twelve months, the Company will need to
raise additional capital through private funding to meet the financial needs of being a reporting
company and to meet the obligations of the current accounts payable.  Historically, the Company has
been successful in either raising operational capital or extending the present loans, or a combination
of both. There is no guarantee that the Company will be successful in obtaining necessary funding
to develop any business opportunities.

During the fourth fiscal quarter the Company entered into an agreement to acquire all of the
equity of eHDL, Inc.  Due to eHDL's failure in meeting their requirements to complete the
acquisition, the transaction has been abandoned

The Company has approached a creditor  for an extension on the note that is due September
30, 2003. The creditor has agreed toextend the due date of the note to September 30, 2004.

**Results of Operations**

The Company reported a net loss of $(14,542) for the year ended September 30, 2003,
compared to a loss of $(88,691) for the previous year. The Company anticipates very little or no
overhead from future operations until a successor business can be acquired or merged.

**ITEM 7. FINANCIAL STATEMENTS**

(a)(1) The following financial statements of the Company and its subsidiaries have been filed as part
of this report:

Independent Auditors' Report

Balance Sheets as of September 30, 2003.

Statements of Operations for the years ended September 30, 2003 and September 30, 2002.

Statement of Stockholders' Equity for the period from October 1, 2000 to September 30, 2003.

Statement of Cash Flows for the years ended September 30, 2003 and September 30, 2002.

Notes to Financial Statements.

(2) Schedules are omitted because of the absence of conditions under which they are required or
because the required information is given in the financial statements or notes thereto.

---



**MedXLink, Corp.**

---



INDEPENDENT AUDITOR'S REPORT

To the Board of Directors
MedXLink, Corp.

We have audited the accompanying balance sheets of MedXLink, Corp., (a Nevada corporation) as
of September 30, 2003 and 2002 and the related statements of operations, stockholders' equity, and
cash flows for the years then ended.  These financial statements are the responsibility of the
company's management.  Our responsibility is to express an opinion on these financial statements
based on our audits.

In our opinion, the financial statements referred to above present fairly, in all material respects, the
financial position of MedXLink, Corp. at September 30, 2003 and 2002, and the results of its
operations and cash flows for the years then ended in conformity with generally accepted accounting
principles, in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will
continue as a going concern.  As discussed in Note 9 to the financial statements, the Company has
minimal assets and no operations and is dependent upon financing to continue operations.  These
factors raise substantial doubt about its ability to continue as a going concern.  Management's plans
in regard to these matters are also described in the Note 9.  The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.

Bierwolf, Nilson & Associates
Salt Lake City, Utah
January 13, 2004

---



**MedXLink, Corp**Balance Sheet

|                                                                                                                                       | ****September 30,


2003 | September 30,


2002
|-------------------------------------------------------------------------------------------------------------------------------------- | ------------------------ | --------------------
|Current Assets                                                                                                                         |                          |                     
|Cash                                                                                                                                   | $	803                    | $	63                
|Interest Receivable                                                                                                                    | -                        | 3,391               
|Note Receivable (Note 5)                                                                                                               | -                        | 195,000             
|Total Assets                                                                                                                           | $	803                    | $	198,454           
|**Liabilities and Stockholders' Equity**                                                                                               |                          |                     
|Current Liabilities                                                                                                                    |                          |                     
|Accounts Payable                                                                                                                       | $	8,292                  | $	79,627            
|Taxes Payable (Note 3)                                                                                                                 | 3,200                    | 2,400               
|Interest Payable (Note 4)                                                                                                              | 11,059                   | 7,271               
|Notes Payable (Note 4)                                                                                                                 | 100,758                  | 220,010             
|Total Current Liabilities                                                                                                              | 123,309                  | 309,308             
|Stockholders' Equity (Deficit)                                                                                                         |                          |                     
|Common Stock; 100,000,000 Shares Authorized;

at $.001 Par Value; 2,487,794 and 2,256,594 Shares

Issued and Outstanding, Respectively | 2,488                    | 2,251               
|Capital in Excess of Par Value                                                                                                         | 296,544                  | 293,885             
|Accumulated Deficit                                                                                                                    | (421,538)                | (406,996)           
|Total Stockholders' Equity (Deficit)                                                                                                   | (122,506)                | (110,854)           
|Total Liabilities & Stockholders' Equity                                                                                               | $	803                    | $	198,454           

---

**MedXLink, Corp.**

|                                    | September 30,

2003 | September 30,

2002
|----------------------------------- | ------------------- | -------------------
|Revenue                             | $-                  | $-                 
|Expenses                            |                     |                    
|General & Administrative            | 7,436               | 85,744             
|Total Expenses                      | 7,436               | 85,744             
|Net Income (Loss) from Operations   | (7,436)             | (85,744)           
|Other Income (Expenses)             |                     |                    
|Interest Income                     | -                   | 3,391              
|Interest Expense                    | (7,106)             | (5,538)            
|Total Expenses                      | (7,106)             | (2,147)            
|Income (Loss) - Before Taxes        | (14,542)            | (87,891)           
|Taxes (Note 3)                      | -                   | -                  
|Net Income (Loss)                   | $	(14,542)          | $	(88,691)         
|Net (Loss) Per Common Share         | $	(.01)             | $	(.35)            
|Weighted Average Outstanding Shares | 2,313,510           | 251,445            

---

**MedXLink, Corp.**Statement of Stockholders' Equity
From October 1, 2001 through September 30, 2003

|                                                    | Common Stock | Capital In


Excess of


Par Value | Accumulated


Deficit
|--------------------------------------------------- | ------------ | ---------------------------------- | ---------------------
|                                                    | Shares       | Amount                            
|Balance, October 1, 2001                            | 250,000      | 250                                | 293,892              
|Rounding Due to 1 to 100

Reverse Stock Split       | 6,594        | 7                                  | (7)                  
|Shares Issued for Relief of Debt
at $.001 Per Share | 2,000,000    | 2,000                              | -                    
|Loss for the Year Ended

September 30, 2002         |              |                                    |                      
|Balance, September 30, 2002                         | 2,256,594    | 2,257                              | 293,885              
|Shares issued for Cash

at $.0125 Per Share         | 231,200      | 231                                | 2,659                
|Loss for the Year Ended
September 30, 2003          |              |                                    |                      
|Balance, September 30, 2003                         | 2,487,794    | $	2,488                            | $	296,544            

---



|                                                          | For the Years Ended September 30,
|--------------------------------------------------------- | ---------------------------------
|                                                          | 2003                             
|Cash Flows from Operating Activities                      |                                  
|Net (Loss)                                                | $	(14,542)                       
|Changes in Operating Assets & Liabilities;                |                                  
|Stock Issued for Relief of Payable                        | -                                
|(Increase) in Interest Receivable                         | 3,391                            
|Increase (Decrease) in Accounts

Payable/Interest Payable | (68,347)                         
|Increase (Decrease) in Taxes Payable                      | 1,600                            
|Net Cash Provided (Used) by

Operating Activities         | (77,898)                         
|Cash Flows from Investing Activities                      |                                  
|Payment for Note Receivable                               | (195,000)                        
|Net Cash Provided (Used) by

Investing Activities         | 195,000                          
|Cash Flows from Financing Activities                      |                                  
|Proceeds from Notes Payable                               | (119,252)                        
|Issuance of Note Payable for Services                     | -                                
|Issuance of Common Stock for Cash                         | 2,890                            
|Net Cash Provided (Used) by 

Financial Activities        | (116,362)                        
|Increase (Decrease) in Cash                               | 740                              
|Cash, Beginning of Period                                 | 63                               
|Cash, End of Period                                       | $	803                            
|Supplemental Disclosure                                   |                                  
|Interest                                                  | $-                               
|Income Taxes (Including Interest & Penalties)             | -                                

---

**MedXLink, Corp.**

The Company was organized in May 1983 in the State of New York under the name of "National
Thoroughbred Corporation."  Subsequently, the name was changed to "NTC Holdings, Inc."  Although
originally formed to engage in purchasing, breeding and selling Thoroughbred horses, the company's
management anticipates merging with an as yet unidentified on-going business in the future.

On July 5, 2002, Articles of Merger were filed with the state of Nevada, merging NTC Holdings, Inc., (a New
York corporation) into Medeport, Inc., (a Nevada Corporation) for the purpose of changing domicile.  On
July 12, 2002, the name was changed from Medeport, Inc., to MedXLink, Corp.  The shareholders agreed
to eliminate the Class A Preferred Stock of one share ($.001 par value) and the Class B Preferred Stock of
1,000,000 shares ($.001 par value).  Both classes of stock had no shares issued or outstanding.Effective July 21, 2002 the Company entered into an agreement to acquire all of the equity of eHDL, Inc.
("eHDL").  In anticipation of the transaction the Company sold approximately $195,000 in debentures and
loaned the proceeds to eHDL.  The transaction was not scheduled to close, however, until and unless eHDL
obtained 1) $1 million in funding, 2) converted its existing debt to equity and 3) obtained audited financial
statements.  Due to eHDL's failure in meeting their requirements to complete the acquisition, the transaction
has been abandoned.

NOTE 2 - Significant Accounting Policies

A.	The Company uses the accrual method of accounting.

B.	Revenues and directly related expenses are recognized in the period when the goods are shipped to,
or services are performed for, the customer.

C.	Primary Earnings Per Share amounts are based on the weighted average number of shares
outstanding at the dates of the financial statements.  Fully Diluted Earnings Per Shares shall be
shown on stock options and other convertible issues that may be exercised within ten years of the
financial statement dates.

D.	Use of Estimates: The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date
of the financial statements and reported amounts of revenues and expenses during the reporting
period.  Actual results could differ from those estimates.

---

****NOTE 3 - Income Taxes

The Company adopted Statement of Financial Standards No. 109 "Accounting for Income taxes" in the fiscal
year ended September 30, 1999 and was applied retroactively.

Statement of Financial Accounting Standards No. 109 "*Accounting for Income Taxes*" requires an asset and
liability approach for financial accounting and reporting for income tax purposes.  This statement recognizes
(a) the amount of taxes payable or refundable for the current year and (b) deferred tax liabilities and assets
for future tax consequences of events that have been recognized in the financial statements or tax returns.

Deferred income taxes result from temporary differences in the recognition of accounting transactions for
tax and financial reporting purposes.   There were no temporary differences at September 30, 2003 and
earlier years; accordingly, no deferred tax liabilities have been recognized for all years.

The Company has cumulative net operating loss carryforwards of approximately $422,000 at September 30,
2003.  No effect has been shown in the financial statements for the net operating loss carryforwards as the
likelihood of future tax benefit from such net operating loss carryforwards is highly improbable.
Accordingly, the potential tax benefits of the net operating loss carryforwards, estimated based upon current
tax rates at September 30, 2003 have been offset by valuation reserves of the same amount.

The Company has available approximately $422,000 in net operating loss carryforwards that will begin to
expire in the year 2003.  The Company has accrued $800 per year minimum state income taxes while it was
a New York Corporation.

NOTE 4 - Notes Payable

Between 2001 and the 2003 year end, the Company has issued numerous promissory notes to other unrelated
parties for operating capital.  The total balance of the notes is $100,758.  The notes are due on demand and
bear interest between the rates of 8% and 10% per annum, some of which are secured by the Company's
common stock.  At September 30, 2003, the total accrued interest was $11,059.

Effective July 21, 2002 the Company entered into an agreement to acquire all of the equity of eHDL, Inc.
("eHDL").  In anticipation of the transaction, the Company sold approximately $195,000 in debentures and
loaned the proceeds to eHDL.  During the 2003 fiscal year, eHDL failed to meet their contractual agreement
necessary to complete the acquisition.  This led to the abandonment of the acquisition between the Company
and eHDL.

Effective July 30, 2003, the debt purchasers agreed that all related funds recorded as notes payable on the
records of  the Company will be recorded as investments into eHDL. The transactions associated with the
investments including accrued interest receivable and payable will be reversed on the books of the Company.

---

**MedXLink, Corp.**

|The Company has the following notes payable obligations:                                                                                       | September


30, 2003 | September


30, 2002
|---------------------------------------------------------------------------------------------------------------------------------------------- | -------------------- | --------------------
|Convertible note payable to investor is due on demand	plus accrued interest at a rate of 8% per annum,	secured by common stock of the Company. | $	5,127              | $	5,127             
|Convertible notes payable to investor are due on demand

plus accrued interest at a rate of 8% or 10% per annum.                               | 95,631               | 19,883              
|Convertible notes payable to investors due within one year

plus accrued interest at a rate of 8% per annum.                                   | -                    | 195,000             
|Totals                                                                                                                                         | $100,758             | $	220,010           
|Less Current Maturities                                                                                                                        | (100,758)            | (220,010)           
|Total Long-Term Notes Payable                                                                                                                  | $	-                  | $-                  

|Following are maturities of long-term debt for each of the next five
years: | Year       | Amount   
|--------------------------------------------------------------------------- | ---------- | ---------
|                                                                            | 2004       | $	100,758
|                                                                            | 2005       | -        
|                                                                            | 2006       | -        
|                                                                            | 2007       | -        
|                                                                            | Thereafter | -        
|                                                                            | Total      | $	100,758

---

**MedXLink, Corp.**

Effective July 21, 2002 the Company entered into an agreement to acquire all of the equity of eHDL, Inc.
("eHDL").  In anticipation of the transaction the Company sold approximately $195,000 in debentures and
loaned the proceeds to eHDL in the form of a note receivable. In June 2003 the Company filed a Complaint
in Florida courts for breach of contract.  As result, the acquisition was  abandoned.  Since the abandonment
all investors have agreed to convert their investment directly in eHD and release the Company from all
covenants and obligations.  eHDL has agreed to assume responsibility for both the notes payable and the note
receivable if the Company dismisses all claims against them.

Effective July 30, 2003, the debt purchasers agreed that all related funds recorded as notes payable on the
records of  the Company will be recorded as investments into eHDL. The transactions associated with the
investments including accrued interest receivable and payable will be reversed on the books of the Company.

During the year, the Company issued a total of 231,200 shares of common stock for cash at $.0125 per share,
accordingly additional paid in capital has been credited by $2,659.

NOTE 7 - Net Earnings (Loss) Per Share

Basic earnings (loss) per common share (BEPS) is based on the weighted-average number of common shares
outstanding during each period.  Diluted earnings (loss) per common share is based on shares outstanding
(computed as under BEPS) and dilutive potential common shares.  Shares from the exercise of the
outstanding options were not included in the computation of diluted loss per share, because their inclusion
would have been antidilutive for the year ended September 30, 2003.

The following data shows the shares used in the computing loss per common share including dilutive
potential common stock;

|Common shares outstanding during the entire period                                                 | 2,313,510
|-------------------------------------------------------------------------------------------------- | ---------
|Weighted-average shares paid for, but not issued during the period                                 | -        
|Weighted-average number of common shares used in basic EPS

dilutive effect of options             | 2,313,510
|Weighted-average number of common shares and dilutive potential

common shares used in diluted EPS | 2,313,510

---

The Company's financial statements are prepared using generally accepted accounting principles applicable
to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal
course of business.  Currently, the Company does not have significant cash or other material assets, nor does
it have an established source of revenues sufficient to cover its operating costs and to allow it to continue
as a going concern.  The Company does not currently possess a financial institution source of financing and
the Company cannot be certain that it's existing sources of cash will be adequate to meet its liquidity
requirements.  However, the Company is undertaking the following approach to meet its liquidity
requirements.

(a)	Seek additional equity funding through private placements to raise sufficient funds to
continue operations and fund its ongoing development, merger and acquisition activities.

(b)	The Company will seek to continue converting certain outstanding loans and payables into
common stock in order to reduce future cash obligations;

(c)	Management is identifying prospective acquisition targets with sufficient cash flow to fund
operations, as well as potentially generating operating cash flow that may sustain corporate
administrative expenses;

The Company's future capital requirements will depend on its ability to successfully implement these
initiatives.

---

**ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING** **AND
FINANCIAL DISCLOSURE**

None.

**ITEM 8A.  CONTROLS AND PROCEDURES**

(a) Evaluation of disclosure controls and procedures.  The Company's principal executive officer
and its principal financial officer, based on their evaluation of the Company's disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 (c) as of a date within 90 days prior to the filing of this
Annual Report on Form 10KSB, have concluded that the Company's disclosure controls and procedures are
adequate and effective for the purposes set forth in the definition in Exchange Act rules.

(b) Changes in internal controls.  There were no significant changes in the Company's internal
controls or in other factors that could significantly affect the Company's internal controls subsequent to the
date of their evaluation.



---

**PART III**



---

The following information is furnished with respect to the Company's Board of Directors and
executive officers. There are no family relationship between or among any of the Company's directors or
executive officers.

|Name                                                             | Age


(2003) | Director


Since | Position with the Company  
|---------------------------------------------------------------- | ------------ | ---------------- | ---------------------------
|Dean Becker

4766 South Holladay Boulevard

Holladay, Utah 84117 | 50           | 1997             | President, CEO and Director

**ITEM 10. EXECUTIVE COMPENSATION**

**Compensation of Executive Officers and Directors**

During the current fiscal year, no one in the Company's management received more than $60,000
in compensation.

**Employment Agreements and Other Compensation Arrangemens**

There are currently no agreements with members of management as to employment or compensation.

**Compensation of Non-Employee Directors**

There is currently no compensation paid to non-employment directors.

---

**ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT**

|Name and Address

Of Beneficial Owner                              | Beneficial

Ownership | Percent of

Class
|------------------------------------------------------------------ | --------------------- | -----------------
|Dean Becker   

4766 South Holladay Boulevard
Holladay, Utah 84117 | 2,005,000             | 80.0%            
|Officers and Directors 

As a Group (one)                          | 2,005,000             | 80.0%            

During the reported year the Registrant did not enter into any other transactions with management
which are to be reported under this Item.

**ITEM  13.    EXHIBITS AND REPORTS ON FORM 8-K.**

(a) Exhibits.  The following exhibits follow the signature page of this report.

32.1  Written Statement of Chief Executive Officer and Chief Financial Officer with respect to
compliance with Section 13(a) or 15(d) of  the Securities Exchange Act of 1934.

(b) The Registrant filed no current reports on Form 8-K during the last quarter of the fiscal year
ended September 30, 2003.

**ITEM 14.  PRINCIPLE ACCOUNTANT FEES AND SERVICES.**

Audit Fees

The aggregate fees billed for professional services rendered by the Company's principal accountant
for the audit of the annual financial statements included in the quarterly reports and other fees that are
normally provided by the accountant in connection with statutory and regulatory filings or engagements for
the fiscal years ended September 30, 2003 and 2002 were $6,060 and $3,975 respectfully.

Audit-Related Fees

The aggregate fees billed for assurance and related services by the Company's principal accountant
that are reasonably related to the performance of the audit or review of the financial statements, other than
those previously reported in this Item 14, for the fiscal years ended September 30, 2003 and 2002 were $0
and $0, respectfully.

Tax Fees

The aggregate fees billed for assurance and related services by the principal accountant for tax
compliance, tax advice and tax planning for the fiscal years ended September 30, 2003 and 2002 were $0 and
$300, respectfully.

All Other Fees

The Company's Board of Directors functions as its audit committee.  All of the services described
above in this Item 14 were approved in advance by the Board of Directors.

---

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant
has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.



By:   Dean Becker/s/ Dean Becker



---

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by
the following persons of behalf of the Registrant and in the capacities and on the dates indicated.

SIGNATURE		TITLE	DATE

/s/ Dean Becker	President and Director
(Principal Executive and
Financial Officer)	January 15, 2004

---

**SECTION 302 CERTIFICATION**

I, Dean Becker, certify that:

1. I have reviewed this annual report on Form 10-KSB of MedXLink, Corp.;

2. Based on my knowledge, this annual report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this annual
report.

3.  Based on my knowledge, the financial statements, and other financial information included in this
annual report, fairly present in all material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this annual report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a) Designed such disclosure controls and procedures to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this annual report is
being prepared.

b) Evaluated the effectiveness of the registrant's disclosure controls and procedures as of
a date within 90 days prior to the filing date of this annual report (the "Evaluation Date");
and

c) Presented in this annual report our conclusions about the effectiveness of the disclosure
controls and procedures based on our evaluation as of the Evaluation Date;

5. I have disclosed, based on our most recent evaluation, to the registrant's auditors and the
audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies in the design or operation of internal controls which could adversely
affect the registrant's ability to record, process, summarize and report financial data and have identified for
the registrant's auditors any material weaknesses in internal controls; and

b) Any fraud, whether or not material, that involves management or other employees who have a
significant role in the registrant's internal controls; and

6.  I have indicated in this annual report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal controls subsequent to the date of our most
recent evaluation, including any corrective actions with regard to significant deficiencies and material
weaknesses.

Date: January    , 2004                                                   /s/Dean Becker
Chief Executive Officer
                                                                               And Principal Accounting Officer

---

EXHIBIT 32.1



(1)The Report fully complies with the requirements of section 13 (a) or 15 (d) of the Securities Exchange
Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition
and result of operations of the Company.

Date: January    , 2004
Dean Becker, Chief Executive Officer
And Principal Accounting Officer

---